多因素助推白酒股全線大漲 瀘州老窖、山西汾酒、五糧液創新高
格隆匯8月25日丨白酒股今日全線大漲,宣佈產品漲價的瀘州老窖漲近6%創歷史新高,口子窖漲5%,酒鬼酒和昨晚公佈了亮眼業績的山西汾酒漲超4%創歷史新高,古井貢酒和五糧液也再創歷史新高,貴州茅台目前漲超1%。消息面上:據格隆匯勾股大數據顯示,茅台一批價升至2780元;山西汾酒昨晚公佈業績顯示,上半年淨利同比大漲33%,增速居已公佈半年報的白酒上市公司第一;瀘州老窖國窖酒類銷售股份有限公司昨日下發通知,全國範圍內自2020年9月10日起,52度國窖1573經典裝結算價上調40元/瓶,38度國窖1573經典裝結算價上調30元/瓶。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.